MedTrace Logo

Study on Yangxue Nao Granules Reducing the Risk of Stroke

NCT04949906 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2021-07-06

No results posted yet for this study

Summary

Objective: To explore the effectiveness of raising serum nao granules in reducing the risk of bleeding in patients with acute ischemic stroke treated with intravenous thrombolysis in the real world

Conditions

  • Cerebral Infarction

Interventions

DRUG

Raise serum brain granules

Should Yangseronao granules be used in patients undergoing intravenous thrombolysis for the diagnosis of acute ischemic stroke

DRUG

No nourishing serum brain granules are used

No nourishing serum brain granules are used

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2020-09-01
Completion
2020-11-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04949906 on ClinicalTrials.gov